X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
humans (49) 49
female (40) 40
oncology (40) 40
male (39) 39
aged (36) 36
colorectal cancer (28) 28
chemotherapy (27) 27
middle aged (27) 27
cancer (25) 25
bevacizumab (17) 17
colorectal neoplasms - drug therapy (17) 17
metastasis (17) 17
adult (16) 16
prognosis (16) 16
aged, 80 and over (15) 15
oxaliplatin (15) 15
colorectal neoplasms - pathology (14) 14
patients (13) 13
tumors (13) 13
analysis (12) 12
care and treatment (12) 12
metastatic colorectal cancer (12) 12
1st-line treatment (11) 11
colorectal carcinoma (11) 11
metastases (11) 11
surgery (11) 11
open-label (10) 10
research (10) 10
survival (10) 10
biomarkers (9) 9
clinical trials (9) 9
therapy (9) 9
capecitabine (8) 8
hematology, oncology and palliative medicine (8) 8
retrospective studies (8) 8
disease-free survival (7) 7
drug therapy (7) 7
fluorouracil (7) 7
neoplasm metastasis (7) 7
pharmacology & pharmacy (7) 7
phase-ii (7) 7
toxicity (7) 7
5-fluorouracil (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
biomarkers, tumor - genetics (6) 6
cetuximab (6) 6
colorectal neoplasms - genetics (6) 6
double-blind (6) 6
elderly (6) 6
follow-up studies (6) 6
irinotecan (6) 6
kras (6) 6
leucovorin (6) 6
liver (6) 6
medical prognosis (6) 6
mutation (6) 6
neoplasm staging (6) 6
prospective studies (6) 6
treatment outcome (6) 6
trial (6) 6
abridged index medicus (5) 5
adenocarcinoma (5) 5
antimitotic agents (5) 5
antineoplastic agents (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
article (5) 5
cancer therapies (5) 5
colon cancer (5) 5
diagnosis (5) 5
health aspects (5) 5
kaplan-meier estimate (5) 5
medical research (5) 5
medicine (5) 5
medicine & public health (5) 5
neurotoxicity (5) 5
panitumumab (5) 5
progression-free survival (5) 5
radiotherapy (5) 5
randomized phase-iii (5) 5
risk groups (5) 5
angiogenesis (4) 4
animals (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
children (4) 4
clinical neurology (4) 4
combination (4) 4
disease progression (4) 4
dosage and administration (4) 4
expression (4) 4
fluorouracil - administration & dosage (4) 4
liver cancer (4) 4
liver diseases (4) 4
medicine, general & internal (4) 4
monoclonal antibodies (4) 4
multivariate analysis (4) 4
neoadjuvant therapy (4) 4
neurosciences (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Bellelli, Giuseppe and Morandi, Alessandro and Di Santo, Simona G and Mazzone, Andrea and Cherubini, Antonio and Mossello, Enrico and Bo, Mario and Bianchetti, Angelo and Rozzini, Renzo and Zanetti, Ermellina and Musicco, Massimo and Ferrari, Alberto and Ferrara, Nicola and Trabucchi, Marco and Boffelli, Stefano and Stefano, Fabio Di and Filippi, Francesco De and Guerini, Fabio and Bertoletti, Erik and March, Albert and Margiotta, Alessandro and Mecocci, Patrizia and Addesi, Desireè and Fantò, Fausto and Dijik, Babette and Porrino, Paola and Cotroneo, Antonino Maria and Galli, Giovanni and Bruni, Amalia Cecilia and Bernardini, Bruno and Corsini, Carla and Cagnin, Annachiara and Zurlo, Amedeo and Barbagallo, Giuseppe and Lunardelli, Maria Lia and Martini, Emilio and Battaglia, Giuseppe and Latella, Raffaele and Petritola, Donatella and Sinforiani, Elena and Cester, Alberto and Formilan, Marino and Carbone, Pasqualina and Appollonio, Ildebrando and Cereda, Diletta and Tremolizzo, Lucio and Bottacchi, Edo and Lucchetti, Lucio and Mariani, Claudio and Rapazzini, Piero and Romanelli, Giuseppe and Marengoni, Alessandra and Zuliani, Giovanni and Bianchi, Lara and Suardi, Teresa and Muti, Ettore and Bottura, Renato and Sgrò, Giovanni and Mandas, Antonella and Serchisu, Luca and Crippa, Patrizia and Ivaldi, Claudio and Ungar, Andrea and Villani, Daniele and Raimondi, Clara and Mussi, Chiara and Isaia, Giancarlo and Provenzano, Giuseppe and Mari, Daniela and Odetti, Patrizio and Monacelli, Fiammetta and Incalzi, Raffaele Antonelli and Pluderi, Alice and Bellamoli, Claudio and Terranova, Luciano and Scarpini, Elio and D'Amico, Ferdinando and Cavallini, Maria Chiara and Guerrini, Gianbattista and Scotuzzi, Anna Maria and Chiarello, Antonino and Pilotto, Alberto and Tognini, Sara and Dell'Aquila, Giuseppina and Toigo, Gabriele and Ceschia, Giuliano and Piccinini, Maristella and Fabbo, Andrea and Zoli, Marco and Forti, Paola and Wenter, Christian and Basile, Giorgio and Lasagni, Anna and Padovani, Alessandro and Rozzini, Luca and Cottino, Maria and Vitali, Silvia and Tripi, Gabriele and Avanzi, Stefano and Annoni, Giorgio and ... and Italian Study Grp Delirium ISGoD and Italian Study Group on Delirium (ISGoD)
BMC Medicine, ISSN 1741-7015, 07/2016, Volume 14, Issue 1, p. 106
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2018, Volume 13, Issue 3, p. e0193640
Journal Article
Scientific Reports, ISSN 2045-2322, 11/2014, Volume 4, Issue 1, pp. 6828 - 6828
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2015, Volume 136, Issue 1, pp. 83 - 90
NRAS mutations occur in 3–5% of colorectal cancer. Differently from KRAS and BRAF mutations, the role of NRAS mutations as prognostic and predictive markers in... 
metastatic colorectal cancer | NRAS | BRAF | KRAS | anti‐EGFR | anti-EGFR | 1ST-LINE TREATMENT | N-RAS | MICROSATELLITE INSTABILITY | KRAS WILD-TYPE | COLON-CANCER | PANITUMUMAB | K-RAS | ONCOLOGY | BRAF MUTATIONS | RAS MUTATIONS | CETUXIMAB PLUS IRINOTECAN | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Mutation, Missense | Liver Neoplasms - mortality | DNA Mutational Analysis | Antibodies, Monoclonal, Humanized - pharmacology | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Cetuximab | Liver Neoplasms - secondary | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Genetic Association Studies | Liver Neoplasms - genetics | Membrane Proteins - genetics | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Biomarkers, Tumor - genetics | Colorectal Neoplasms - pathology | Chemotherapy | Gene mutations | Analysis | Colorectal cancer | Monoclonal antibodies | Genetic aspects | Metastasis | Cancer | Mutation | Medical prognosis | Tumors
Journal Article
14.